Declan Doogan of Amarin to Keynote CHI’s Conference on Phase III Clinical Trials | PRLog

Declan Doogan of Amarin to Keynote CHI’s Conference on Phase III Clinical Trials PRLog

Zelboraf: A Major Focal Point at CHI’s 2nd Annual Oncology Clinical Trials Conference | PRLog

Zelboraf: A Major Focal Point at CHI’s 2nd Annual Oncology Clinical Trials Conference PRLog

CHI Adds Cloud Computing Programming to the 2012 Molecular Med TRI-CON | PRLog

CHI Adds Cloud Computing Programming to the 2012 Molecular Med TRI-CON PRLog

Christopher Austin, M.D., Named as Keynote Speaker at CHI’s 3D Tissue Models Conference | PRLog

Christopher Austin, M.D., Named as Keynote Speaker at CHI’s 3D Tissue Models Conference PRLog

CHI Announces its 2nd Annual Stem Cells in Drug Discovery and Development Conference | PRLog

CHI Announces its 2nd Annual Stem Cells in Drug Discovery and Development Conference PRLog

Sponsors Announced for CHI's Accelerating Proof of Concept Conference in Philadelphia | PRLog

Sponsors Announced for CHI's Accelerating Proof of Concept Conference in Philadelphia PRLog

Cambridge Healthtech Institute Organizes a Summit on Immunogenicity Prediction & Mitigation

Cambridge Healthtech Institute Organizes a Summit on Immunogenicity Prediction & Mitigation